Date	Chamber	Action
8/4/2023	House	Public Act . . . . . . . . . 103-0420

Statutes Amended In Order of Appearance

5 ILCS 375/6.11

55 ILCS 5/5-1069.3

65 ILCS 5/10-4-2.3

105 ILCS 5/10-22.3f

215 ILCS 5/356z.61 new

215 ILCS 125/5-3

from Ch. 111 1/2, par. 1411.2

215 ILCS 130/4003

from Ch. 73, par. 1504-3

215 ILCS 165/10

from Ch. 32, par. 604

305 ILCS 5/5-16.8

Synopsis As Introduced
Amends the Illinois Insurance Code. Provides that a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed on or after January 1, 2024 and that provides coverage for prescription drugs shall provide coverage for vaginal estrogen, and that coverage for vaginal estrogen shall not impose a deductible, coinsurance, copayment, or any other cost-sharing requirement. Makes conforming changes in the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, the Limited Health Service Organization Act, the Voluntary Health Services Plans Act, and the Medical Assistance Article of the Illinois Public Aid Code.

House Floor Amendment No. 2
Provides that a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed on or after January 1, 2025 (rather than January 1, 2024) and that provides coverage for prescription drugs shall include coverage for one or more therapeutic equivalent versions of vaginal estrogen in its formulary.

Senate Committee Amendment No. 1
Provides that if (rather than if an individual's attending provider recommends) a particular vaginal estrogen product or its therapeutic equivalent version approved by the United States Food and Drug Administration is determined to be medically necessary (rather than based on the provider's determination), the issuer must cover that service or item pursuant to the cost-sharing requirement in specified provisions (rather than without cost sharing). Provides that a policy subject to the provisions shall not impose a deductible, coinsurance, copayment, or any other cost-sharing requirement that exceeds any deductible, coinsurance, copayment, or any other cost-sharing requirement imposed on any prescription drug authorized for the treatment of erectile dysfunction covered by the policy (rather than on the coverage provided). Removes language providing that a policy is not required to include all therapeutic equivalent versions of vaginal estrogen in its formulary so long as at least one is included and covered without cost sharing and in accordance with the provisions.

Actions 

Date	Chamber	Action
1/30/2023	House	Filed with the Clerk by Rep. Katie Stuart
1/31/2023	House	First Reading
1/31/2023	House	Referred to Rules Committee
2/15/2023	House	Assigned to Insurance Committee
2/28/2023	House	House Committee Amendment No. 1 Filed with Clerk by Rep. Katie Stuart
2/28/2023	House	House Committee Amendment No. 1 Referred to Rules Committee
2/28/2023	House	Do Pass / Short Debate Insurance Committee; 013-001-000
2/28/2023	House	House Committee Amendment No. 1 Tabled
3/1/2023	House	Added Co-Sponsor Rep. Kelly M. Cassidy
3/1/2023	House	Placed on Calendar 2nd Reading - Short Debate
3/6/2023	House	Added Co-Sponsor Rep. Lilian Jiménez
3/14/2023	House	Second Reading - Short Debate
3/14/2023	House	Placed on Calendar Order of 3rd Reading - Short Debate
3/16/2023	House	House Floor Amendment No. 2 Filed with Clerk by Rep. Katie Stuart
3/16/2023	House	House Floor Amendment No. 2 Referred to Rules Committee
3/16/2023	House	Added Co-Sponsor Rep. Mary Beth Canty
3/16/2023	House	Added Co-Sponsor Rep. Laura Faver Dias
3/16/2023	House	Added Co-Sponsor Rep. Will Guzzardi
3/16/2023	House	Added Co-Sponsor Rep. Maura Hirschauer
3/16/2023	House	Added Co-Sponsor Rep. Robyn Gabel
3/16/2023	House	Added Co-Sponsor Rep. Jennifer Gong-Gershowitz
3/16/2023	House	Added Co-Sponsor Rep. Suzanne M. Ness
3/20/2023	House	House Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 004-000-000
3/23/2023	House	Recalled to Second Reading - Short Debate
3/23/2023	House	House Floor Amendment No. 2 Adopted by Voice Vote
3/23/2023	House	Placed on Calendar Order of 3rd Reading - Short Debate
3/23/2023	House	Third Reading - Short Debate - Passed 108-000-001
3/24/2023	Senate	Arrive in Senate
3/24/2023	Senate	Placed on Calendar Order of First Reading
3/24/2023	Senate	Chief Senate Sponsor Sen. Meg Loughran Cappel
3/24/2023	Senate	First Reading
3/24/2023	Senate	Referred to Assignments
4/12/2023	Senate	Assigned to Insurance
4/14/2023	Senate	Senate Committee Amendment No. 1 Filed with Secretary by Sen. Meg Loughran Cappel
4/14/2023	Senate	Senate Committee Amendment No. 1 Referred to Assignments
4/18/2023	Senate	Senate Committee Amendment No. 1 Assignments Refers to Insurance
4/18/2023	Senate	Senate Committee Amendment No. 1 Adopted; Insurance
4/19/2023	Senate	Do Pass as Amended Insurance; 011-000-000
4/19/2023	Senate	Placed on Calendar Order of 2nd Reading April 20, 2023
4/25/2023	Senate	Second Reading
4/25/2023	Senate	Placed on Calendar Order of 3rd Reading April 26, 2023
5/4/2023	Senate	Third Reading - Passed; 057-000-000
5/8/2023	House	Arrived in House
5/8/2023	House	Placed on Calendar Order of Concurrence Senate Amendment(s) 1
5/9/2023	House	Senate Committee Amendment No. 1 Motion Filed Concur Rep. Katie Stuart
5/9/2023	House	Senate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee
5/15/2023	House	Senate Committee Amendment No. 1 Motion to Concur Referred to Insurance Committee
5/16/2023	House	Senate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Insurance Committee; 012-000-000
5/17/2023	House	Senate Committee Amendment No. 1 House Concurs 113-000-000
5/17/2023	House	House Concurs
5/17/2023	House	Passed Both Houses
6/15/2023	House	Sent to the Governor
8/4/2023	House	Governor Approved
8/4/2023	House	Effective Date January 1, 2024
8/4/2023	House	Public Act . . . . . . . . . 103-0420

Back To Top